Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 312 results for "glenmark pharmaceuticals"

Overweight on Glenmark Pharma shares, target price Rs 686
Financial Express

Overweight on Glenmark Pharma shares, target price Rs 686

Limited competition in gDDAVP indicates an attractive opportunity for Glenmark. (Reuters) Summary We are overweight on Glenmark Pharma with a target price of R686. We are overweight on Glenmark Pharmaceuticals Ltd with a target price of R686. Financial Express, 9 hours ago
Overweight on Glenmark Pharma, target Rs 686 Financial Express, 11 hours ago

15 images for glenmark pharmaceuticals

Financial Express, 2 hours ago
Tutorial Finder, 1 week ago
Drug Discovery and Development, 1 week ago
India TV, 1 month ago
Money Control, 1 month ago
Rediff.com, 2 months ago
Rediff.com, 2 months ago
Financial Express, 3 months ago
Financial Express, 2 months ago
The Hindu, 2 months ago
Financial Express

Glenmark recalls 2,904 bottles of Rantidine tablets in US mkt

Glenmark Pharmaceuticals is voluntarily recalling 2,904 bottles of Rantidine Tablets, used to treat ulcers of the stomach and intestines, in the US market, according to the US Food and Drug Administration. According to information available on the USFDA ...
 Business Standard3 hours ago Glenmark Pharmaceuticals recalls 2,904 bottles of Rantidine tablets in US mkt  Financial Express2 hours ago
Livemint.com

Glenmark's insomnia drug, eszopiclone tablets receives US FDA approval

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics Limited has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for eszopiclone tablets. Glenmark will commence ...
 PharmaBiz1 day ago Glenmark Generics receives approval for Eszopiclone tablets  Express Pharma1 day ago Glenmark receives final approval for Lunesta copy  Livemint.com1 day ago Glenmark Pharmaceuticals adds up to its portfolio  Capital Market1 day ago
[x]  
Rediff.com

PTI - DRL-GLENMARK(BCM9) - Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod

DRL-GLENMARK(BCM9) - Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod Contributed by NAMPA / PTI. Hyderabad, Apr 16 (PTI) Pharma major Dr Reddy's Laboratories today said it has launched a drug to treat insomnia in the US market, ...
 Namibia Press Agency1 day ago Dr Reddy's launches insomnia drug in US; Glenmark gets FDA nod  Economic Times1 day ago Dr Reddy’s launches insomnia drug in US, Glenmark gets FDA nod  Business Line1 day ago Dr Reddy's launches Eszopiclone tablets in US  Hindu Business Line1 day ago
[x]  

US approvals key to Glenmark's prospects

Operations here and in other countries continue to fare well; earnings growth to pick up in FY15 as new US product launches gain momentum Ujjval Jauhari | Mumbai April 9, 2014 Last Updated at 21:42 IST Glenmark Pharmaceuticals has seen an increase ...
 Business Standard India1 week ago US approvals hold key to Glenmark's prospects  Smart Investor1 week ago
Livemint.com

GLENMARK PHARMACEUTICALS : Molecule to enter human trials

04/10/2014 | 02:51am US/Eastern Recommend: 0 Glenmark Pharmaceuticals Ltd is planning human trials in the UK for its pain management drug candidate GRC 27864. It has completed pre-clinical trials. The company hopes to ...
 4 Traders1 week ago Glenmark''s Novel Molecule ''GRC 27864'' for Chronic Inflammatory Diseases Including Pain Entering Human Trials  Asian Hospital & Healthcare Management1 week ago Glenmark's new pain management molecule to enter human trials in UK  Livemint.com2 weeks ago Glenmark’s novel molecule ‘GRC 27864’ entering human trials  India Infoline2 weeks ago
[x]  

With rate sensitives getting back into flavor, expect less action in pharma pack: Avinnash Gorakssakar

If you look at Lupin, Sun or Glenmark, despite the fact that there have been some issues on the US FDA front, the core earnings continues to be solid. In an interview with ET Now, Avinnash Gorakssakar, Head of Research, Miintdirect.com, shares his views on ...
 Economic Times1 week ago

Glenmark's chronic inflammatory disease drug enters human trials

Glenmark Pharmaceuticals' Novel Chemical Entity (NCE) 'GRC 27864' is entering human trials. This NCE program targets Microsomal Prostaglandin E synthase-1 (mPGES-1) as a novel therapeutic target in pain management. Selective mPGES-1 inhibitors are ...
 Indian-Commodity1 week ago Glenmark's novel molecule for chronic inflammatory diseases enters human trials  PharmaBiz2 weeks ago Glenmark Pharmaceuticals' Novel Chemical Entity (NCE) 'GRC 27864' is entering human trials  Equity Bulls1 week ago
Financial Express

Regulator imposes limits on use of 2 OTC painkillers

In a move that could affect sales of drug majors like Wockhardt, Lupin, Glenmark and Ranbaxy, the regulator has restricted usage of painkillers tramadol and tapentadol. Based on the recommendations of the new drug advisory committee, the usage of ...
 Financial Express1 week ago India's patents moves could see particular uncertainty for diabetes sector  Pharma Letter1 month ago
Money Control

Patent suits go up, AZ sues Glenmark on Onglyza

The Delhi High Court though has ordered a status quo on this case while Glenmark claims to have no intention of launching the drug in India.
 Money Control1 week ago Patent suits go up, AstraZeneca sues Glenmark on Onglyza  FirstWord Pharma1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - glenmark pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less